| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Biological and Technological Research and Infectious Diseases Clinic, San Raffaele Scientific Institute, Milano, Italy;
Istituto Biocatalisi e Riconoscimento Molecolare, Consiglio Nazionale delle Ricerche, Milano, Italy;
Malattie Infettive, Ospedale S.M. Annunziata, Firenze, Italy;
§
Cattedra di Immunologia, Università di Milano, Milano, Italy; and
¶
Dipartimento di Biologia e Genetica per le Scienze Mediche, Milano, Italy
Exposure to HIV does not necessarily results in infection. Because primary HIV infection is associated with CCR5-tropic HIV variants (R5), CCR5-specific Abs in the sera of HIV-seronegative, HIV-exposed individuals (ESN) might be associated with protection against infection. We analyzed sera from ESN, their HIV-infected sexual partners (HIV+), and healthy controls (USN) searching for CCR5-specific Abs, studying whether incubation of PBMC with sera could prevent macrophage inflammatory protein 1ß (Mip1ß) (natural ligand of CCR5) binding to CCR5. Results showed that Mip1ß binding to CCR5 was not modified by sera of either 40 HIV+ or 45 USN but was greatly reduced by sera of 6/48 ESN. Binding inhibition was due to Abs reactive with CCR5. The CCR5-specific Abs neutralized the infectivity of primary HIV isolates obtained from the corresponding HIV+ partners and of R5-primary HIV strains, but not that of CXCR4-tropic or amphitropic HIV strains. Immunoadsorption on CCR5-transfected, but not on CXCR4-transfected, cells removed CCR5-specific and virus-neutralizing Abs. Epitope mapping on purified CCR5-specific Abs showed that these Abs recognize a conformational epitope in the first cysteine loop of CCR5 (aa 89–102). Affinity-purified anti-CCR5-peptide neutralized the infectivity of R5 strains of HIV-1. Anti-CCR5 Abs inhibited Mip1ß-induced chemotaxis of PBMC from healthy donors. PBMC from two ESN (with anti-CCR5 Abs) were CCR5-negative and could not be stimulated by Mip1ß in chemotaxis assays. These results contribute to clarifying the phenomenon of immunologic resistance to HIV and may have implications for the development of a protective vaccine.
This article has been cited by other articles:
|
|
 |
|
  C. Pastori, A. Clivio, L. Diomede, R. Consonni, G. M. S. De Mori, R. Longhi, G. Colombo, and L. Lopalco Two Amino Acid Substitutions within the First External Loop of CCR5 Induce Human Immunodeficiency Virus-Blocking Antibodies in Mice and Chickens J. Virol., April 15, 2008; 82(8): 4125 - 4134. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. I. Lobo, K. H. Schlegel, W. Yuan, G. C. Townsend, and J. A. White Inhibition of HIV-1 Infectivity through an Innate Mechanism Involving Naturally Occurring IgM Anti-Leukocyte Autoantibodies J. Immunol., February 1, 2008; 180(3): 1769 - 1779. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Pallikkuth, A. Wanchu, A. Bhatnagar, R. K. Sachdeva, and M. Sharma Human Immunodeficiency Virus (HIV) gag Antigen-Specific T-Helper and Granule-Dependent CD8 T-Cell Activities in Exposed but Uninfected Heterosexual Partners of HIV Type 1-Infected Individuals in North India Clin. Vaccine Immunol., September 1, 2007; 14(9): 1196 - 1202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Babaahmady, W. Oehlmann, M. Singh, and T. Lehner Inhibition of Human Immunodeficiency Virus Type 1 Infection of Human CD4+ T Cells by Microbial HSP70 and the Peptide Epitope 407-426 J. Virol., April 1, 2007; 81(7): 3354 - 3360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. Friedrich, L. E. Valentine, L. J. Yant, E. G. Rakasz, S. M. Piaskowski, J. R. Furlott, K. L. Weisgrau, B. Burwitz, G. E. May, E. J. Leon, et al. Subdominant CD8+ T-Cell Responses Are Involved in Durable Control of AIDS Virus Replication J. Virol., April 1, 2007; 81(7): 3465 - 3476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Pastori, B. Weiser, C. Barassi, C. Uberti-Foppa, S. Ghezzi, R. Longhi, G. Calori, H. Burger, K. Kemal, G. Poli, et al. Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression Blood, June 15, 2006; 107(12): 4825 - 4833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Misumi, D. Nakayama, M. Kusaba, T. Iiboshi, R. Mukai, K. Tachibana, T. Nakasone, M. Umeda, H. Shibata, M. Endo, et al. Effects of Immunization with CCR5-Based Cycloimmunogen on Simian/HIVSF162P3 Challenge J. Immunol., January 1, 2006; 176(1): 463 - 471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Nakayama, S. Misumi, R. Mukai, K. Tachibana, M. Umeda, H. Shibata, N. Takamune, and S. Shoji Suppression of Multiclade R5 and X4 Human Immunodeficiency Virus Type-1 Infections by a Coreceptor-Based Anti-HIV Strategy J. Biochem., November 1, 2005; 138(5): 571 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Barassi, E. Soprana, C. Pastori, R. Longhi, E. Buratti, F. Lillo, C. Marenzi, A. Lazzarin, A. G. Siccardi, and L. Lopalco Induction of Murine Mucosal CCR5-Reactive Antibodies as an Anti-Human Immunodeficiency Virus Strategy J. Virol., June 1, 2005; 79(11): 6848 - 6858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Bouhlal, V. Latry, M. Requena, S. Aubry, S. V. Kaveri, M. D. Kazatchkine, L. Belec, and H. Hocini Natural Antibodies to CCR5 from Breast Milk Block Infection of Macrophages and Dendritic Cells with Primary R5-Tropic HIV-1 J. Immunol., June 1, 2005; 174(11): 7202 - 7209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Lopalco, C. Barassi, C. Paolucci, D. Breda, D. Brunelli, M. Nguyen, J. Nouhin, T. T. Luong, L. X. Truong, M. Clerici, et al. Predictive value of anti-cell and anti-human immunodeficiency virus (HIV) humoral responses in HIV-1-exposed seronegative cohorts of European and Asian origin J. Gen. Virol., February 1, 2005; 86(2): 339 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Devito, B. Zuber, U. Schroder, R. Benthin, K. Okuda, K. Broliden, B. Wahren, and J. Hinkula Intranasal HIV-1-gp160-DNA/gp41 Peptide Prime-Boost Immunization Regimen in Mice Results in Long-Term HIV-1 Neutralizing Humoral Mucosal and Systemic Immunity J. Immunol., December 1, 2004; 173(11): 7078 - 7089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Barassi, A. Lazzarin, and L. Lopalco CCR5-specific mucosal IgA in saliva and genital fluids of HIV-exposed seronegative subjects Blood, October 1, 2004; 104(7): 2205 - 2206. [Full Text] [PDF]
|
|
|
|
|
|
B. Chackerian, L. Briglio, P. S. Albert, D. R. Lowy, and J. T. Schiller Induction of Autoantibodies to CCR5 in Macaques and Subsequent Effects upon Challenge with an R5-Tropic Simian/Human Immunodeficiency Virus J. Virol., April 15, 2004; 78(8): 4037 - 4047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Misumi, R. Nakajima, N. Takamune, and S. Shoji A Cyclic Dodecapeptide-Multiple-Antigen Peptide Conjugate from the Undecapeptidyl Arch (from Arg168 to Cys178) of Extracellular Loop 2 in CCR5 as a Novel Human Immunodeficiency Virus Type 1 Vaccine J. Virol., December 1, 2001; 75(23): 11614 - 11620. [Abstract] [Full Text]
|
|
|
|
|
|
T. Lehner, C. Doyle, Y. Wang, K. Babaahmady, T. Whittall, L. Tao, L. Bergmeier, and C. Kelly Immunogenicity of the Extracellular Domains of C-C Chemokine Receptor 5 and the In Vitro Effects on Simian Immunodeficiency Virus or HIV Infectivity J. Immunol., June 15, 2001; 166(12): 7446 - 7455. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Bouhlal, H. Hocini, C. Quillent-Gregoire, V. Donkova, S. Rose, A. Amara, R. Longhi, N. Haeffner-Cavaillon, A. Beretta, S. V. Kaveri, et al. Antibodies to C-C Chemokine Receptor 5 in Normal Human IgG Block Infection of Macrophages and Lymphocytes with Primary R5-Tropic Strains of HIV-1 J. Immunol., June 15, 2001; 166(12): 7606 - 7611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Devito, K. Broliden, R. Kaul, L. Svensson, K. Johansen, P. Kiama, J. Kimani, L. Lopalco, S. Piconi, J. J. Bwayo, et al. Mucosal and Plasma IgA from HIV-1-Exposed Uninfected Individuals Inhibit HIV-1 Transcytosis Across Human Epithelial Cells J. Immunol., November 1, 2000; 165(9): 5170 - 5176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cota, M. Mengozzi, E. Vicenzi, P. Panina-Bordignon, F. Sinigaglia, P. Transidico, S. Sozzani, A. Mantovani, and G. Poli Selective inhibition of HIV replication in primary macrophages but not T lymphocytes by macrophage-derived chemokine PNAS, August 1, 2000; 97(16): 9162 - 9167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Blanpain, J.-M. Vanderwinden, J. Cihak, V. Wittamer, E. Le Poul, H. Issafras, M. Stangassinger, G. Vassart, S. Marullo, D. Schlondorff, et al. Multiple Active States and Oligomerization of CCR5 Revealed by Functional Properties of Monoclonal Antibodies Mol. Biol. Cell, February 1, 2002; 13(2): 723 - 737. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
